Document is current
Any future updates will be listed below
-
Authors
Brian, Jessica
Solish, Abbie
Leef, Jonathan
Nguyen, Jenny
Bickle, Laura
Budovitch, Robyn
Chan, Victoria
Drouillard, Brianne
Drumm, Ellen
Genore, Lisa
Adams, Rianne Hastie
Hermolin, Robin
Klemencic, Nora
Lambert, Maude
Lee, Kristina
Lim, Janys
Mak-Fan, Kathleen
O’Neill, Monica
Price, Stephanie
Pye, Melissa
Selezneva, Elizabeth
Taheri, Azin
Anagnostou, Evdokia
-
Funding
Funding for this research was provided by:
Ministry of Health, Ontario
Ministry of Health
Ministry of Health (Ontario) - grant # 705
- License Information
-
More Information
Article History
Received: 27 October 2023
Accepted: 30 January 2025
First Online: 27 February 2025
Declarations
:
: EA reports the following potential conflicts: Grants from industry (Roche, SynpDx, Maplight, Anavex; Sanofi Aventis), consultations (ROChe, Ono, Impel, Cell-EI, Quadrant) and in-kind supports (AMO pharma, CRA), editorial honoraria/ book royalties (Wiley, APPI, Springer), and a patent (Anxiety Meter). All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be perceived as a potential or actual conflicts of interest.
: This study involving human participants was approved by the Research Ethics Board at Holland Bloorview Kids Rehabilitation Hospital. The study was conducted in accordance with local legislation and institutional requirements. Participants provided written informed consent as described in the manuscript.
